ArticleJournal of fluorescence2025
Chitosan-Based Schiff Base Compounds: Synthesis, Chemical Characterization and Antibacterial Properties.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Piperazine linked chitosan schiff base nanoparticles as a novel antibiofilm and antibacterial strategy against clinically relevant pathogens.Scientific reports · 2026Article
- Chitosan-quinoxaline Schiff base hydroxyapatite composite with antimicrobial properties for bone regeneration.Scientific reports · 2026Article
- Synthesis and biological study of thiopheneyl/piperazinl-α-aminophosphonate-chitosan conjugates as biologically active carriers for controlled delivery of curcumin.Scientific reports · 2026Article
- Comparative Study of Corrosion Inhibition Properties of Q345 Steel by Chitosan MOF and Chitosan Schiff Base.Materials (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The focus of the study was the synthesis, characterization, and investigation of the antibacterial properties of chitosan Schiff bases (CHSB) and crosslinked chitosan Schiff bases (CCHSB) resulting from the reaction of chitosan with 2,3-dihydroxybenzaldehyde and epichlorohydrin. The physicochemical properties of the synthesized compounds were analyzed using 1H NMR, FTIR, XRD, SEM, and TGA techniques. The chemical shifts of chitosan appeared between 1.78 and 4.71 ppm. Aromatic ring protons from the Schiff base appeared between 6.68 and 7.79 ppm. Epichlorohydrin methylene protons for crosslinking were observed as triplets in the range of 1.24-1.04 ppm in the 1 H-NMR spectrum of cross-linked Schiff bases. The antibacterial activity of the chitosan and Schiff base derivatives on gram-negative bacteria (Escherichia coli and Salmonella typhimurium) and gram-positive bacteria (Staphylococcus aureus and Bacillus cereus) was compared with the drugs amikacin and gentamicin. Results showed that the chitosan derivatives exhibited antibacterial properties, with inhibition zones ranging from 8 to 30 mm. Chitosan derivatives demonstrated antibacterial activity comparable to standard drugs like amikacin and gentamicin, suggesting their potential as effective alternatives or adjuncts in treatments. These findings indicate that chitosan and its derivatives have the potential to be utilized as effective antibacterial agents or alternatives in a variety of medical domains. Additionally, chitosan derivatives may serve as natural preservatives in the food industry by inhibiting microbial growth, thereby extending the shelf life of perishable products and ensuring their quality and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.